Why the study?
Does oral tocainide reduce premature ventricular contractions compared to pre-drug placebo?
Population
15 patients with premature ventricular contractions (PVCs)
Comparison
Tocainide (oral antiarrhythmic agent) vs Pre-drug placebo controls
Design
Case_series
Follow-up
short-term
Authors
Loading...
May suppress PVCs in select patients without side effects; leaves open need for randomized trials before any practice change.
Does oral tocainide reduce premature ventricular contractions compared to pre-drug placebo?
Tocainide demonstrates linear kinetics and effectively suppresses premature ventricular contractions during short-term administration, with mild transient CNS toxicity at peak doses.
Winkle et al. (1976) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: